Premium Nahrungsergänzungsmittel | artgerecht

Ipamorelin – Growth Hormone Peptide Explained

Ipamorelin is a synthetic peptide that selectively stimulates the release of growth hormone. It is being studied for various clinical and research applications.

Regular tips about health Regular tips about health

Things worth knowing about "Ipamorelin"

Ipamorelin is a synthetic peptide that selectively stimulates the release of growth hormone. It is being studied for various clinical and research applications.

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide (composed of five amino acids) belonging to the class of growth hormone secretagogues (GHS). Developed in the 1990s, it is known for selectively and controllably stimulating the release of growth hormone (GH) from the pituitary gland. Unlike some other GH secretagogues, ipamorelin has minimal impact on other hormone levels such as cortisol or prolactin, making it a subject of significant research interest.

Mechanism of Action

Ipamorelin acts as an agonist at the ghrelin receptor (also known as GHS-R1a, the Growth Hormone Secretagogue Receptor). By binding to this receptor in the pituitary gland and hypothalamus, it triggers a dose-dependent release of growth hormone. It also inhibits the activity of somatostatin, a natural suppressor of GH secretion, further enhancing GH release.

Selective stimulation of GH secretion
Minimal influence on cortisol, ACTH, or prolactin
Combination with GHRH analogues (e.g., CJC-1295) is frequently studied in research

Medical Applications

Ipamorelin remains largely in the preclinical and clinical research phase. Potential applications that have been investigated in studies include:

Growth hormone deficiency: Support for patients with clinically confirmed GH deficits
Postoperative recovery: Studies explored its use in promoting gastrointestinal function after surgery (postoperative ileus)
Sarcopenia and muscle wasting: Research into reducing age-related muscle loss
Bone health: Potential positive effects on bone mineral density
Body composition: Reduction of body fat while preserving lean muscle mass

Dosage and Usage Notes

In clinical studies, ipamorelin was typically administered via subcutaneous injection. Dosages studied varied depending on the research objective. A standardized, officially approved dosing recommendation for human clinical use does not currently exist, as ipamorelin is not an approved pharmaceutical in most countries. Its use outside of clinical trials therefore occurs in a regulatory grey area.

Side Effects and Safety Profile

Ipamorelin is generally considered well tolerated compared to other growth hormone secretagogues. Side effects observed in clinical studies include:

Mild injection site reactions (redness, swelling)
Temporary fatigue or drowsiness
Headache
Water retention (edema) at higher doses
Possible influence on insulin levels

Because ipamorelin affects the growth hormone axis, particular caution is advised in individuals with active malignancies, diabetes, or other hormonal disorders. Medical supervision is strongly recommended.

Legal Status

In most countries, including those in the European Union and the United States, ipamorelin is not approved as a pharmaceutical drug. It is used exclusively for research purposes. Obtaining and using it without a prescription within a clinical protocol may have legal consequences. In some countries, the substance is monitored by anti-doping authorities due to its potential for misuse in competitive sports.

References

Raun K, Hansen BS, Johansen NL et al. - Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 1998; 139(5): 552-561.
Svensson J, Lall S, Dickson SL et al. - The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. Journal of Endocrinology, 2000; 165(3): 569-577.
Greenwood-Van Meerveld B, Tyler K, Mohammadi E et al. - Effects of ipamorelin on gastrointestinal motility in the context of postoperative ileus. Journal of Pharmacology and Experimental Therapeutics, 2012.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.